Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.01 USD | -1.19% | +0.32% | +30.67% |
05-13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.67% | 2.26B | |
-6.21% | 12.23B | |
-3.86% | 8.17B | |
+5.92% | 5.78B | |
+33.66% | 5.74B | |
-7.35% | 4.24B | |
-55.63% | 2.97B | |
+13.62% | 2.73B | |
-3.85% | 2.38B | |
-4.31% | 1.87B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Jefferies Raises Myriad Genetics' Price Target to $22 From $19, Hold Rating Kept